Found: 1
Select item for more details and to access through your institution.
Phase II study of SU5416a small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitorin patients with refractory myeloproliferative diseases.
- Published in:
- Cancer (0008543X), 2003, v. 97, n. 8, p. 1920
- By:
- Publication type:
- Article